Cathie Wood Is Selling This High-Yield Dividend Stock. Should You?
Cathie Wood and high dividend yields go together like... well, it's hard to finish that sentence because they don't go together at all. Wood and her Ark Invest funds are known for investing in innovative growth stocks, not stocks with exceptionally attractive dividends.
But (NYSE: PFE) stood out as an exception to the rule. Wood initiated a position in the big drugmaker for her Ark Genomic Innovation ETF in 2021. However, she has sold this high-yield dividend stock in recent months. Should you sell Pfizer too?
At the end of 2023, Wood's Ark Genomic Innovation ETF owned nearly 500,000 shares of Pfizer. Only 16 days later, the holding was drastically reduced after Wood sold more than 337,000 shares. More selling would follow shortly.
Source Fool.com
Pfizer Inc. Aktie
Die Community bevorzugt Pfizer Inc., mit deutlich mehr Buy- (30) als Sell-Einschätzungen (4).
Ein Kursziel von 41 € für Pfizer Inc. würde eine Steigerung von mehr als 50% gegenüber dem aktuellen Kurs von 23.73 € bedeuten.
